Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A stimuli-responsive, controlled release bilayer for the prevention of
bacterial infection
on biomaterials is presented. Drug release is locally controlled by the pH-responsiveness of the bilayer, comprised of an inner poly(acrylic acid) (
PAA
) monolayer grafted to a biomaterial and cross-linked with an outer chitosan (CH) brush. Tobramycin (TOB) is loaded in the inner
PAA
in part to minimize bacteria resistance. Because biofilm formation causes a decrease in local pH, TOB is released from
PAA
and permeates through the CH, which is in contact with the biofilm. Antibiotic capacity is controlled by the
PAA
thickness, which depends on
PAA
brush length and the extent of cross-linking between CH and
PAA
at the bilayer interface. This TOB-loaded, pH-responsive bilayer exhibits significantly enhanced antibacterial activity relative to controls.
...
PMID:Targeted release of tobramycin from a pH-responsive grafted bilayer challenged with S. aureus. 2558 73